Cite
HARVARD Citation
Bai, Y. et al. (n.d.). 128PTislelizumab in combination with chemotherapy for Chinese patients (Pts) with gastric/gastroesophageal junction cancer (GC/GEJC) or esophageal squamous cell carcinoma (ESCC). Annals of oncology. p. . [Online].